Market Summary | Major Indices | Market Movers | Market Sectors | Mutual Funds | A-Z Stock Listings
ETF Screener | World Markets | Currencies | CEO Wealthmeter | Oil / Energy | Metals
Treasury Rates | Calculators | My Watchlist | My Portfolio
         Symbol Lookup
CYCLACEL PHARMA Add to My Watchlist (NSDQ: CYCC) 
Detailed Quote
News
Chart
SEC Filings
Profile
Historical
Options
     Cyclacel 2.04 -0.06 (-2.86%) 1,519,683
200 Connell Drive
Suite 1500
Berkeley Heights, NJ 07922 US
(908) 517-7330
(866) 271-3466 fax
www.cyclacel.com
CEO Spiro Rombotis
Auditor Ernst & Young LLP
Exchange Traded NQ
ISIN Number US23254L1089
CIK Number 1130166
NAICS Code 325412
Business Summary
A biopharmaceutical company, dedicated to the discovery, development and commercialization of novel, mechanism-targeted drugs to treat human cancers and other serious disorders.
Number of Employees 51
Share Fundamentals
Market Cap 49.84M
Shares Outstanding 24.43M
Float 23.67M
Short Interest 27.74K
Financial Strength
Revenue (TTM) $975,000
Earnings (TTM) -$23,175,000
Quick Ratio 1.5:1
Current Ratio 1.7:1
Total Debt/Equity 0:1
Profitability
Gross Margin N/A
EBITDA Margin N/A
Profit Margin N/A
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Market News provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs